“nice writing! maybe nash will be our ticket too? little or no competition from bp.”

Yes, if the NASH results of good, I believe that will help in brining leronlimab to the top. Like you said, they aren’t any good NASH drugs out there so BP will be interested in a drug that shows promise.

Now let’s get that NASH trial enrolled!